1.0Bendigo Timeshttps://timesnewsgroup.com.au/bendigotimesNew trial for skin cancer treatments - Bendigo Timesrich600338<blockquote class="wp-embedded-content" data-secret="24zlMoVfR0"><a href="https://timesnewsgroup.com.au/bendigotimes/news/new-trial-for-skin-cancer-treatments/">New trial for skin cancer treatments</a></blockquote><iframe sandbox="allow-scripts" security="restricted" src="https://timesnewsgroup.com.au/bendigotimes/news/new-trial-for-skin-cancer-treatments/embed/#?secret=24zlMoVfR0" width="600" height="338" title="“New trial for skin cancer treatments” — Bendigo Times" data-secret="24zlMoVfR0" frameborder="0" marginwidth="0" marginheight="0" scrolling="no" class="wp-embedded-content"></iframe><script>
/*! This file is auto-generated */
!function(d,l){"use strict";l.querySelector&&d.addEventListener&&"undefined"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!/[^a-zA-Z0-9]/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret="'+t.secret+'"]'),o=l.querySelectorAll('blockquote[data-secret="'+t.secret+'"]'),c=new RegExp("^https?:$","i"),i=0;i<o.length;i++)o[i].style.display="none";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute("style"),"height"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):"link"===t.message&&(r=new URL(s.getAttribute("src")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener("message",d.wp.receiveEmbedMessage,!1),l.addEventListener("DOMContentLoaded",function(){for(var e,t,s=l.querySelectorAll("iframe.wp-embedded-content"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute("data-secret"))||(t=Math.random().toString(36).substring(2,12),e.src+="#?secret="+t,e.setAttribute("data-secret",t)),e.contentWindow.postMessage({message:"ready",secret:t},"*")},!1)))}(window,document);
//# sourceURL=https://timesnewsgroup.com.au/bendigotimes/wp-includes/js/wp-embed.min.js
</script>
https://static.timesnewsgroup.com.au/prod/uploads/sites/24/2021/11/20160701001269463902-original-e1638228935609.jpg1000663BENDIGO melanoma patients are trialling a drug commonly used in prostate and breast cancer treatments to determine its effectiveness against skin cancer. The CHARLI trial will see nine patients from the Bendigo cancer centre, diagnosed with metastatic melanoma, have the drug denosumab added to their standard immunotherapies. “We hope the addition of denosumab to current [...]Read More...